The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Celgene; Celgene; Celgene; Celgene
Research Funding - Celgene; Celgene; Celgene; Celgene

Efficacy and safety of second-line nab-paclitaxel plus gemcitabine (nab-P+GEM) after progression on first-line FOLFIRINOX in advanced pancreatic ductal adenocarcinoma (PDAC): Multicenter retrospective analysis.
 
Changhoon Yoo
No Relationships to Disclose
 
Hyehyun Jeong
No Relationships to Disclose
 
Heejung Chae
No Relationships to Disclose
 
Jaekyung Cheon
No Relationships to Disclose
 
Hong Jae Chon
No Relationships to Disclose
 
Hyewon Ryu
No Relationships to Disclose
 
Il-Hwan Kim
No Relationships to Disclose
 
Jae Ho Jeong
No Relationships to Disclose
 
Kyu-Pyo Kim
No Relationships to Disclose
 
Baek-Yeol Ryoo
No Relationships to Disclose